Cronos Q4 2022 Revenue Declines 11% YoY, What About Net Loss?

Zinger Key Points

Cronos Group Inc. CRON CRON net revenue in 2022 was $91.9 million, a 23% increase compared to $74.4 million in 2021.

Q4 2022 Financial Highlights

  • Net revenue of $22.9 million, an 11% decrease compared to $25.8 million in Q4 2021.

  • Gross loss was $234,000, compared to a gross profit of $1.9 million in Q4 2021.

  • Adjusted EBITDA was a loss of $21.2 million in Q4 2022 improved by $6.1 million from Q4 2021.

  • Net loss was $78.9 million, a 41% decrease compared to a loss of $133.9 million in Q4 2021.

  • Cash and cash equivalents at the end of the period were $764,644.

Full-Year 2022 Financial Highlights

  • Gross profit was $12.0 million, a 168% increase compared to a gross loss of $17.5 million in 2021.

  • Gross margin was 13% compared to a negative gross margin of 24% in 2021.

  • Adjusted EBITDA was a loss of $80.6 million compared to a loss of $160.4 million in 2021.

  • Net loss was $168.7 million, a 58% decrease compared to a loss of $397.2 million in 2021.

“2022 was a transformative year for Cronos in which we executed a business realignment, including a cost savings program, while staying laser focused on continuing to build our portfolio of borderless products,” stated Mike Gorenstein, chairman, president and CEO of Cronos. “We exceeded our originally stated goal by saving $28.7 million in operating expenses in 2022, to right-size our cost structure to be more adaptable to the changing landscape we face globally in the cannabis industry. A significant amount of work went into building the Spinach brand and creating the right products for it, which culminated in the brand achieving the number one market share in the Canadian edibles category in January 2023.”

Benzinga's Cannabis Capital Conference Is Back

The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will surge very soon.

Photo by Richard T on Unsplash

CRON Logo
CRONCronos Group Inc
$1.842.21%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
21.75
Growth
85.95
Quality
-
Value
65.74
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:

Cannabis is evolving—don’t get left behind!

Curious about what’s next for the industry and how to stay ahead in today’s competitive market?

Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.

Secure your spot now before prices go up—this is where the biggest deals and connections happen!

Get your tickets today!

Comments
Loading...